Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnteq Tech Regulatory News (NTQ)

Share Price Information for Enteq Tech (NTQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.75
Bid: 8.00
Ask: 9.50
Change: 0.00 (0.00%)
Spread: 1.50 (18.75%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.00
NTQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

30 Apr 2012 07:00

RNS Number : 2961C
Enteq Upstream PLC
30 April 2012
 

Enteq Upstream plc

("Enteq" or the "Company")

Board appointment

Enteq, the oil and gas field services company, which has today announced the conditional acquisition of substantially all of the operating assets and certain liabilities of XXT Incorporated ("XXT") (the "Acquisition") has also conditionally raised approximately £40.2 million (net of expenses) by way of a placing of 42,000,000 new ordinary shares (the "Placing").

The Company is pleased to announce that Ian Leaman, Enteq's interim Chief Financial Officer, was appointed to the Board of Directors as Chief Financial Officer on 27 April 2012. Ian Leaman was also appointed to the role of Company Secretary.

Ian David Leaman (50 years old) is a Chartered Accountant who qualified with Deloitte (then Touche Ross). Subsequently, Ian has held both chief financial officer and advisory positions and has specialised in corporate finance, advising businesses in various sectors, both public and private, in acquisitions, disposals and fundraisings. He is Vice-Chairman of the Institute of Chartered Accountants in England and Wales's Corporate Finance Faculty and is a non-executive director of Octopus VCT3 plc.

For further information, please contact:

Enteq Upstream plc

+44 (0) 20 7861 3232

Martin Perry, Chief Executive Officer

Ian Leaman, Chief Financial Officer

Investec Bank plc

+44 (0) 20 7597 5970

James Grace, Patrick Robb

David Anderson

Pelham Bell Pottinger

+44 (0) 20 7861 3232

Mark Antelme, Charlie Stewart

 

Additional disclosures pursuant to Schedule 2(g) of the AIM Rules:

Current directorships and partnerships:

Past five years' directorships and partnerships:

Buckingham Corporate Finance Ltd

Buckingham & Cavour Limited

Leaman Advisory Limited

Luxe Locations LLP

Octopus VCT 3 PLC

Timeless Releasing LLP

 

There is no other information that is required to be disclosed with regards to the appointment of Ian Leaman pursuant to Schedule 2 paragraph (g) of the AIM Rules.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABLGDSXBDBGDC
Date   Source Headline
10th Apr 20247:00 amRNSYear-end Trading Update
11th Jan 20249:12 amRNSHolding(s) in Company
8th Jan 20243:59 pmRNSHolding(s) in Company
24th Nov 20237:00 amRNSPresenting at the MelloLondon Conference
15th Nov 20237:00 amRNSHalf-year Report
2nd Nov 202310:25 amRNSDirector/PDMR Shareholding
30th Oct 20234:08 pmRNSResult of General Meeting
23rd Oct 20237:00 amRNSAwards under the Enteq Performance Share Plan
18th Oct 202311:07 amRNSInvestor Presentation via Investor Meet Company
10th Oct 20237:00 amRNSAppointment of Non-Executive Director
6th Oct 20232:25 pmRNSHolding(s) in Company
4th Oct 20237:00 amRNSHolding(s) in Company
29th Sep 20237:00 amRNSAGM Statement and Board Update
22nd Sep 20233:29 pmRNSNotice of Final Results
19th Sep 20232:53 pmRNSHolding(s) in Company
6th Sep 20237:00 amRNSNotice of Annual General Meeting
9th Aug 20238:25 amRNSSABER System Field Trial Update
31st Jul 20239:30 amRNSNotice of Final Results
1st Jun 20232:30 pmRNSIssue of Shares and Director/PDMR Shareholdings
1st Jun 20237:00 amRNSAppointment of new CFO
12th Apr 20237:00 amRNSSale of XXT and Year-end Trading Update
29th Mar 20237:08 amRNSSale of Property
15th Feb 20237:00 amRNSSABER Tool Update
16th Nov 20221:25 pmRNSDirector/PDMR Shareholding
16th Nov 20227:00 amRNSInterim Results
21st Sep 20223:36 pmRNSResult of AGM
21st Sep 20229:05 amRNSSecond Price Monitoring Extn
21st Sep 20229:00 amRNSPrice Monitoring Extension
21st Sep 20227:00 amRNSAGM Trading Statement
2nd Aug 20225:43 pmRNSIssue of Shares and Director/PDMR Shareholding
8th Jul 20223:10 pmRNSDirector/PDMR Shareholding
6th Jul 20227:00 amRNSFinal Results and Investor Presentation
14th Apr 20221:00 pmRNSDirector/PDMR Shareholding
7th Apr 20227:00 amRNSYear-end Trading Update
8th Mar 20229:06 amRNSHolding(s) in Company
3rd Mar 20221:47 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSBusiness Update and SABER Technology Progress
23rd Dec 202110:42 amRNSHolding(s) in Company
15th Dec 20213:39 pmRNSIssue of Shares and Director/PDMR Shareholding
18th Nov 20217:00 amRNSInterim Results
10th Nov 20217:00 amRNSExclusive Distributor Agreements Signed
8th Nov 20217:00 amRNSSABER Tool – Field Trial Update
28th Oct 20217:00 amRNSChange of Name
30th Sep 20214:05 pmRNSDirector/PDMR Shareholding
23rd Sep 20213:22 pmRNSResult of General Meeting and Change of Name
23rd Sep 20217:00 amRNSAGM Trading Statement
10th Aug 202110:30 amRNSDirector/PDMR Shareholding
26th Jul 20215:04 pmRNSDirector/PDMR Shareholding
14th Jul 20214:25 pmRNSIssue of shares and Director/PDMR Shareholding
7th Jul 20217:00 amRNSFinal Results & Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.